BSACI position statement: Cost of living, health inequalities and the adverse additional impact on children and young people living with allergic conditions VIEW HERE
BSACI statement: NICE approval of Palforzia, a treatment for peanut allergy in children and young people VIEW HERE
26 Jun 2024 Announcements, Latest news, BSACI guidance for prescribing Palforzia® Peanut Oral Immunotherapy published
